Grifols, S.A. (BME:GRF)
Spain · Delayed Price · Currency is EUR 12.96
+0.11 (0.86%)
Aug 8, 2025, 5:38 PM CET
Patterson Companies Market Cap
Grifols has a market cap or net worth of €7.91 billion as of August 8, 2025. Its market cap has increased by 36.51% in one year.
Market Cap
7.91B
Enterprise Value
19.40B
Revenue
7.45B
Ranking
n/a
PE Ratio
28.68
Stock Price
$12.96
Market Cap Chart
Since May 18, 2006, Grifols's market cap has increased from 729.00M to 7.91B, an increase of 985.27%. That is a compound annual growth rate of 13.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 7.91B | 39.27% |
| Dec 31, 2024 | 5.68B | -38.46% |
| Dec 29, 2023 | 9.23B | 40.77% |
| Dec 30, 2022 | 6.56B | -32.97% |
| Dec 30, 2021 | 9.78B | -30.92% |
| Dec 31, 2020 | 14.16B | -24.52% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Laboratorios Farmaceuticos Rovi | 2.72B |
| Almirall | 2.21B |
| Pharma Mar | 1.39B |
| Faes Farma | 1.31B |
| Clínica Baviera | 714.61M |
| Laboratorio Reig Jofre | 245.77M |
| Atrys Health | 212.57M |
| Oryzon Genomics | 204.63M |